Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × exemestane × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 53 Neoplasms 5 Neoplasm Metastasis 5 Carcinoma, Intraductal, Noninfiltrating 3 Ovarian Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms by Site 1 Multiple Endocrine Neoplasia Type 1 1 Locoregional Recurrence 1 Hyperglycemia 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 HER2-positive Breast Cancer 1 Granulosa cell tumor of the ovary 1 Endometrial Hyperplasia 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Specimen Handling 7 Tamoxifen 5 Practice Guidelines as Topic 5 Standard of Care 4 Radiotherapy 3 Methods 3 Sentinel Lymph Node Biopsy 2 Radiation 2 Interviews as Topic 2 Educational Status 2 Early Intervention, Educational 2 Counseling 2 pembrolizumab 1 exemestane 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 abemaciclib 1 Watchful Waiting 1 Telemedicine 1 Taxes 1 Tablets 1 Surveys and Questionnaires 1 Starch 1 Reverse Transcriptase Polymerase Chain Reaction 1 Ranitidine 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Protons 1 Proton Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06671912 2026-03-04

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡